Kynam Capital Management, LP

Holdings History for Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)

Symbol: SNDX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 8,520,000 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Kynam Capital Management, LP ownership in Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX)

14 Feb 2025 - Kynam Capital Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,520,000 shares of Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX). This represents 10% ownership of the company. This is the first filing by Kynam Capital Management, LP disclosing ownership of Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Kynam Capital Management, LP	10%		$113,571,600	8,520,000			$13.33	13G/A	31 Dec 2024	14 Feb 2025, 17:18

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		9.8%	0%	$131,080,200	8,520,000	0		$15.38	Q3 2025
30 Jun 2025		8.6%	0%	$79,789,800	8,520,000	0		$9.36	Q2 2025
31 Mar 2025		9%	0%	$104,668,200	8,520,000	0		$12.28	Q1 2025
31 Dec 2024		7.4%	+2.3%	$112,634,400	8,520,000	+2,677,075	+46%	$13.22	Q4 2024
30 Sep 2024		8.7%	+0.18%	$112,476,306	5,842,925	+120,868	+2.1%	$19.25	Q3 2024
30 Jun 2024		12%	+0.14%	$117,473,830	5,722,057	+62,057	+1.1%	$20.53	Q2 2024
31 Mar 2024		15%	0%	$134,708,000	5,660,000	0		$23.80	Q1 2024
31 Dec 2023		14%	+5%	$122,312,600	5,660,000	+2,060,000	+57%	$21.61	Q4 2023
31 Dec 2023	call		-59%	$0	0	-400,000	-100%		Q4 2023
30 Sep 2023		8.7%	+0.82%	$52,272,000	3,600,000	+337,996	+10%	$14.52	Q3 2023
30 Sep 2023	call	59%	+59%	$5,808,000	400,000	+400,000	NEW	$14.52	Q3 2023
30 Jun 2023		10%	+0.18%	$68,273,744	3,262,004	+56,018	+1.7%	$20.93	Q2 2023
31 Mar 2023		8.8%	+1.8%	$67,710,424	3,205,986	+644,799	+25%	$21.12	Q1 2023
31 Dec 2022		10%	+1.1%	$65,182,209	2,561,187	+288,272	+13%	$25.45	Q4 2022
30 Sep 2022		12%	-1.2%	$54,618,000	2,272,915	-239,325	-9.5%	$24.03	Q3 2022
30 Jun 2022		12%	+2.9%	$48,335,000	2,512,240	+579,440	+30%	$19.24	Q2 2022
31 Mar 2022		11%	+5.5%	$33,592,000	1,932,800	+976,635	+102%	$17.38	Q1 2022
31 Dec 2021		11%	0%	$20,930,000	956,165	0		$21.89	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.